Sintx Technologies (SINT) Competitors

$2.40 +0.02 (+0.84%)

Closing price 04:00 PM Eastern

Extended Trading

$2.50 +0.10 (+4.17%)

As of 06:34 PM Eastern

SINT vs. CTSO, AGPU, NMTC, STRR, and POCI

Should you buy Sintx Technologies stock or one of its competitors? MarketBeat compares Sintx Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sintx Technologies include Cytosorbents (CTSO), Predictive Oncology (AGPU), NeuroOne Medical Technologies (NMTC), Star Equity (STRR), and Precision Optics (POCI). These companies are all part of the "medical equipment" industry.

How does Sintx Technologies compare to Cytosorbents?

Cytosorbents (NASDAQ:CTSO) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

32.9% of Cytosorbents shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 7.3% of Cytosorbents shares are held by insiders. Comparatively, 4.1% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cytosorbents has higher revenue and earnings than Sintx Technologies. Cytosorbents is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytosorbents	$37.06M	0.92	-$8.20M	-$0.13	N/A
Sintx Technologies	$729K	13.57	-$10.36M	-$5.66	N/A

Cytosorbents has a net margin of -22.12% compared to Sintx Technologies' net margin of -1,018.08%. Cytosorbents' return on equity of -150.53% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytosorbents	-22.12%	-150.53%	-32.75%
Sintx Technologies	-1,018.08%	-242.76%	-99.86%

In the previous week, Cytosorbents had 4 more articles in the media than Sintx Technologies. MarketBeat recorded 6 mentions for Cytosorbents and 2 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.93 beat Cytosorbents' score of -0.22 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cytosorbents	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cytosorbents presently has a consensus price target of $5.38, suggesting a potential upside of 892.06%. Sintx Technologies has a consensus price target of $11.00, suggesting a potential upside of 358.33%. Given Cytosorbents' higher possible upside, research analysts plainly believe Cytosorbents is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Cytosorbents has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, Sintx Technologies has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

Summary

Cytosorbents beats Sintx Technologies on 11 of the 16 factors compared between the two stocks.

How does Sintx Technologies compare to Predictive Oncology?

Predictive Oncology (NASDAQ:AGPU) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

In the previous week, Predictive Oncology and Predictive Oncology both had 2 articles in the media. Predictive Oncology's average media sentiment score of 0.93 equaled Sintx Technologies'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Predictive Oncology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sintx Technologies has a net margin of -1,018.08% compared to Predictive Oncology's net margin of -185,476.72%. Predictive Oncology's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Predictive Oncology	-185,476.72%	N/A	-970.41%
Sintx Technologies	-1,018.08%	-242.76%	-99.86%

9.0% of Predictive Oncology shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 1.2% of Predictive Oncology shares are held by insiders. Comparatively, 4.1% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Sintx Technologies has a consensus price target of $11.00, suggesting a potential upside of 358.33%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Sintx Technologies is more favorable than Predictive Oncology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Sintx Technologies has higher revenue and earnings than Predictive Oncology. Predictive Oncology is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Predictive Oncology	$125.28K	247.58	-$233.10M	-$12.62	N/A
Sintx Technologies	$729K	13.57	-$10.36M	-$5.66	N/A

Predictive Oncology has a beta of 3.45, meaning that its stock price is 245% more volatile than the broader market. Comparatively, Sintx Technologies has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

Summary

Sintx Technologies beats Predictive Oncology on 11 of the 14 factors compared between the two stocks.

How does Sintx Technologies compare to NeuroOne Medical Technologies?

Sintx Technologies (NASDAQ:SINT) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

In the previous week, NeuroOne Medical Technologies had 5 more articles in the media than Sintx Technologies. MarketBeat recorded 7 mentions for NeuroOne Medical Technologies and 2 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.93 beat NeuroOne Medical Technologies' score of 0.20 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeuroOne Medical Technologies	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

NeuroOne Medical Technologies has a net margin of -68.35% compared to Sintx Technologies' net margin of -1,018.08%. NeuroOne Medical Technologies' return on equity of -92.06% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-1,018.08%	-242.76%	-99.86%
NeuroOne Medical Technologies	-68.35%	-92.06%	-66.04%

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Sintx Technologies presently has a consensus price target of $11.00, indicating a potential upside of 358.33%. NeuroOne Medical Technologies has a consensus price target of $11.67, indicating a potential upside of 153.62%. Given Sintx Technologies' higher probable upside, equities research analysts plainly believe Sintx Technologies is more favorable than NeuroOne Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

NeuroOne Medical Technologies has higher revenue and earnings than Sintx Technologies. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$729K	13.57	-$10.36M	-$5.66	N/A
NeuroOne Medical Technologies	$9.72M	3.98	-$3.61M	-$0.85	N/A

Sintx Technologies has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

Summary

NeuroOne Medical Technologies beats Sintx Technologies on 10 of the 16 factors compared between the two stocks.

How does Sintx Technologies compare to Star Equity?

Sintx Technologies (NASDAQ:SINT) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

In the previous week, Star Equity had 5 more articles in the media than Sintx Technologies. MarketBeat recorded 7 mentions for Star Equity and 2 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.93 beat Star Equity's score of -0.02 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Star Equity	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Star Equity has a net margin of -4.18% compared to Sintx Technologies' net margin of -1,018.08%. Star Equity's return on equity of -4.09% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-1,018.08%	-242.76%	-99.86%
Star Equity	-4.18%	-4.09%	-2.49%

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 33.5% of Star Equity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Sintx Technologies has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Star Equity has a beta of 0.43, meaning that its share price is 57% less volatile than the broader market.

Sintx Technologies currently has a consensus target price of $11.00, indicating a potential upside of 358.33%. Star Equity has a consensus target price of $16.50, indicating a potential upside of 65.66%. Given Sintx Technologies' higher possible upside, research analysts plainly believe Sintx Technologies is more favorable than Star Equity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Star Equity	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Star Equity has higher revenue and earnings than Sintx Technologies. Star Equity is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$729K	13.57	-$10.36M	-$5.66	N/A
Star Equity	$172.16M	0.21	-$5.92M	-$2.05	N/A

Summary

Star Equity beats Sintx Technologies on 10 of the 17 factors compared between the two stocks.

How does Sintx Technologies compare to Precision Optics?

Sintx Technologies (NASDAQ:SINT) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

Precision Optics has higher revenue and earnings than Sintx Technologies. Precision Optics is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$729K	13.57	-$10.36M	-$5.66	N/A
Precision Optics	$19.09M	1.94	-$5.78M	-$0.92	N/A

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 14.4% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Sintx Technologies currently has a consensus target price of $11.00, indicating a potential upside of 358.33%. Given Sintx Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe Sintx Technologies is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Precision Optics had 7 more articles in the media than Sintx Technologies. MarketBeat recorded 9 mentions for Precision Optics and 2 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.93 beat Precision Optics' score of 0.18 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Precision Optics	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Precision Optics has a net margin of -28.33% compared to Sintx Technologies' net margin of -1,018.08%. Precision Optics' return on equity of -60.56% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-1,018.08%	-242.76%	-99.86%
Precision Optics	-28.33%	-60.56%	-32.67%

Sintx Technologies has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Precision Optics has a beta of 0.23, meaning that its share price is 77% less volatile than the broader market.

Summary

Sintx Technologies and Precision Optics tied by winning 8 of the 16 factors compared between the two stocks.

Get Sintx Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SINT vs. The Competition

Export

Metric	Sintx Technologies	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$9.89M	$6.69B	$6.29B	$12.40B
Dividend Yield	N/A	1.72%	2.79%	5.30%
P/E Ratio	-0.42	49.55	20.89	25.59
Price / Sales	13.57	43.30	523.43	63.12
Price / Cash	N/A	24.21	42.94	55.34
Price / Book	3.00	6.50	9.86	6.70
Net Income	-$10.36M	$158.34M	$3.55B	$333.77M
7 Day Performance	0.42%	-2.49%	-0.33%	0.45%
1 Month Performance	-14.29%	-1.90%	1.34%	4.06%
1 Year Performance	-30.43%	-1.85%	41.10%	36.24%

Sintx Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SINT Sintx Technologies	3.501 of 5 stars	$2.40 +0.8%	$11.00 +358.3%	-28.1%	$9.89M	$729K	N/A	40	Upcoming Earnings
CTSO Cytosorbents	1.8416 of 5 stars	$0.59 -7.0%	$5.38 +817.4%	-34.4%	$39.50M	$37.06M	N/A	220	News Coverage Earnings Report
AGPU Predictive Oncology	1.0692 of 5 stars	$6.66 flat	N/A	N/A	$36.89M	$120K	N/A	30
NMTC NeuroOne Medical Technologies	4.1318 of 5 stars	$4.39 +1.4%	$13.50 +207.5%	+16.7%	$36.46M	$12.10M	N/A	20	Earnings Report Analyst Downgrade Short Interest Decrease
STRR Star Equity	4.4145 of 5 stars	$9.48 +0.2%	$16.50 +74.1%	+322.7%	$35.07M	$172.16M	N/A	1,200	Earnings Report Analyst Revision High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SINT) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sintx Technologies (SINT) Competitors

SINT vs. CTSO, AGPU, NMTC, STRR, and POCI

How does Sintx Technologies compare to Cytosorbents?

Summary

How does Sintx Technologies compare to Predictive Oncology?

Summary

How does Sintx Technologies compare to NeuroOne Medical Technologies?

Summary

How does Sintx Technologies compare to Star Equity?

Summary

How does Sintx Technologies compare to Precision Optics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SINT vs. The Competition

Sintx Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sintx Technologies (SINT) Competitors

SINT vs. CTSO, AGPU, NMTC, STRR, and POCI

How does Sintx Technologies compare to Cytosorbents?

Do institutionals & insiders hold more shares of CTSO or SINT?

Which has stronger valuation & earnings, CTSO or SINT?

Is CTSO or SINT more profitable?

Does the media refer more to CTSO or SINT?

Do analysts recommend CTSO or SINT?

Which has more risk and volatility, CTSO or SINT?

Summary

How does Sintx Technologies compare to Predictive Oncology?

Does the media refer more to AGPU or SINT?

Is AGPU or SINT more profitable?

Do institutionals & insiders hold more shares of AGPU or SINT?

Do analysts recommend AGPU or SINT?

Which has stronger valuation & earnings, AGPU or SINT?

Which has more risk and volatility, AGPU or SINT?

Summary

How does Sintx Technologies compare to NeuroOne Medical Technologies?

Does the media favor SINT or NMTC?

Is SINT or NMTC more profitable?

Do insiders and institutionals believe in SINT or NMTC?

Do analysts rate SINT or NMTC?

Which has preferable earnings and valuation, SINT or NMTC?

Which has more risk and volatility, SINT or NMTC?

Summary

How does Sintx Technologies compare to Star Equity?

Does the media favor SINT or STRR?

Is SINT or STRR more profitable?

Do institutionals and insiders believe in SINT or STRR?

Which has more volatility & risk, SINT or STRR?

Do analysts rate SINT or STRR?

Which has higher earnings & valuation, SINT or STRR?

Summary

How does Sintx Technologies compare to Precision Optics?

Which has higher earnings & valuation, SINT or POCI?

Do institutionals and insiders believe in SINT or POCI?

Do analysts rate SINT or POCI?

Does the media favor SINT or POCI?

Is SINT or POCI more profitable?

Which has more volatility & risk, SINT or POCI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SINT vs. The Competition

Sintx Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools